Last edition
News about "USFDA Inspection "
Supriya Lifescience Receives US FDA EIR with VAI Status for Lote Parshuram Facility
Supriya Lifescience receives US FDA EIR with VAI classification for its Lote Parshuram facility, closing the February 2026 audit inspection cycle.
USFDA Inspection | 23/04/2026 | By News Bureau | 119
Morepen Laboratories Bags Zero-Observation USFDA Inspection for Fourth Time
Morepen Laboratories clears its fourth consecutive USFDA inspection at the Masulkhana facility with zero observations (NIL 483), reinforcing its CDMO strength following a INR 825 crore global manufacturing mandate.
USFDA Inspection | 21/04/2026 | By News Bureau | 102
Torrent Pharma's Vizag API Unit Passes USFDA Inspection with Zero Observation
The US Food and Drug Administration (USFDA) has completed the inspection of Torrent Pharma's API manufacturing facility located in Vizag, Andhra Pradesh.
USFDA Inspection | 04/08/2025 | By Dineshwori | 922
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy